Publication
Randomised, open-label, phase II study comparing the efficacy and the safety of cabazitaxel versus weekly paclitaxel given as neoadjuvant treatment in patients with operable triple-negative or luminal B/HER2-negative breast cancer (GENEVIEVE)
Journal Paper/Review - Jul 30, 2017
Kümmel Sherko, Burchardi Nicole, von Minckwitz Gunter, Fasching Peter A, Klare Peter, Engels Knut, Denkert Carsten, Schneeweiss Andreas, Jackisch Christian, Hilfrich Jörn, Hanusch Claus, Gerber Bernd, Eiermann Wolfgang, Blohmer Jens Uwe, Untch Michael, Schem Christian, Huober Jens, Paepke Stefan, Loibl Sibylle
Kümmel, Sherko
29
0
Paepke, Stefan
12
0
Huober, Jens
chief physicianBrustzentrum St.Gallen, Medizinische Onkologie und Hämatologie · Dept. IV, Dept. I
288
11
Schem, Christian
16
0
Untch, Michael
88
0
Blohmer, Jens Uwe
5
0
Eiermann, Wolfgang
6
0
Gerber, Bernd
49
0
Hanusch, Claus
42
0
Hilfrich, Jörn
25
0
Jackisch, Christian
69
0
Schneeweiss, Andreas
77
0
Denkert, Carsten
49
0
Engels, Knut
11
0
Klare, Peter
8
0
Fasching, Peter A
74
0
von Minckwitz, Gunter
59
0
Burchardi, Nicole
5
0
Loibl, Sibylle
84
0